Taiwan · Delayed Price · Currency is TWD BioGend Therapeutics Statistics
Total Valuation
TPEX:6733 has a market cap or net worth of TWD 4.90 billion. The enterprise value is 4.35 billion.
| Market Cap | 4.90B |
| Enterprise Value | 4.35B |
Important Dates
The next estimated earnings date is Friday, November 7, 2025.
| Earnings Date | Nov 7, 2025 |
| Ex-Dividend Date | n/a |
Share Statistics
TPEX:6733 has 124.26 million shares outstanding. The number of shares has decreased by -0.02% in one year.
| Current Share Class | 124.26M |
| Shares Outstanding | 124.26M |
| Shares Change (YoY) | -0.02% |
| Shares Change (QoQ) | -0.95% |
| Owned by Insiders (%) | 4.18% |
| Owned by Institutions (%) | 2.56% |
| Float | 75.07M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | 25.10 |
| PB Ratio | 6.22 |
| P/TBV Ratio | 7.49 |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Enterprise Valuation
| EV / Earnings | -34.23 |
| EV / Sales | 22.31 |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | -57.57 |
Financial Position
The company has a current ratio of 21.53, with a Debt / Equity ratio of 0.01.
| Current Ratio | 21.53 |
| Quick Ratio | 20.95 |
| Debt / Equity | 0.01 |
| Debt / EBITDA | n/a |
| Debt / FCF | -0.10 |
| Interest Coverage | -734.06 |
Financial Efficiency
Return on equity (ROE) is -15.13% and return on invested capital (ROIC) is -9.58%.
| Return on Equity (ROE) | -15.13% |
| Return on Assets (ROA) | -9.04% |
| Return on Invested Capital (ROIC) | -9.58% |
| Return on Capital Employed (ROCE) | -16.14% |
| Revenue Per Employee | n/a |
| Profits Per Employee | n/a |
| Employee Count | n/a |
| Asset Turnover | 0.21 |
| Inventory Turnover | 3.01 |
Taxes
| Income Tax | -8.31M |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has increased by +3.01% in the last 52 weeks. The beta is 0.14, so TPEX:6733's price volatility has been lower than the market average.
| Beta (5Y) | 0.14 |
| 52-Week Price Change | +3.01% |
| 50-Day Moving Average | 36.94 |
| 200-Day Moving Average | 32.72 |
| Relative Strength Index (RSI) | 43.95 |
| Average Volume (20 Days) | 1,385,949 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, TPEX:6733 had revenue of TWD 195.02 million and -127.10 million in losses. Loss per share was -1.04.
| Revenue | 195.02M |
| Gross Profit | 146.01M |
| Operating Income | -131.40M |
| Pretax Income | -136.56M |
| Net Income | -127.10M |
| EBITDA | -85.07M |
| EBIT | -131.40M |
| Loss Per Share | -1.04 |
Balance Sheet
The company has 575.56 million in cash and 7.58 million in debt, giving a net cash position of 567.98 million or 4.57 per share.
| Cash & Cash Equivalents | 575.56M |
| Total Debt | 7.58M |
| Net Cash | 567.98M |
| Net Cash Per Share | 4.57 |
| Equity (Book Value) | 786.82M |
| Book Value Per Share | 6.15 |
| Working Capital | 644.34M |
Cash Flow
In the last 12 months, operating cash flow was -75.02 million and capital expenditures -560,000, giving a free cash flow of -75.58 million.
| Operating Cash Flow | -75.02M |
| Capital Expenditures | -560,000 |
| Free Cash Flow | -75.58M |
| FCF Per Share | -0.61 |
Margins
Gross margin is 74.87%, with operating and profit margins of -67.38% and -65.18%.
| Gross Margin | 74.87% |
| Operating Margin | -67.38% |
| Pretax Margin | -70.03% |
| Profit Margin | -65.18% |
| EBITDA Margin | -43.62% |
| EBIT Margin | -67.38% |
| FCF Margin | n/a |
Dividends & Yields
TPEX:6733 does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | 0.02% |
| Shareholder Yield | n/a |
| Earnings Yield | -2.60% |
| FCF Yield | -1.54% |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | n/a |
| Lynch Upside | n/a |
| Graham Number | n/a |
| Graham Upside | n/a |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
TPEX:6733 has an Altman Z-Score of 42.92 and a Piotroski F-Score of 2.
| Altman Z-Score | 42.92 |
| Piotroski F-Score | 2 |